InspireMD to Present at the 23rd Annual Needham Virtual Healthcare Conference
InspireMD to Present at the 23rd Annual Needham Virtual Healthcare Conference
TEL AVIV, Israel and MIAMI, April 03, 2024 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard Embolic Prevention Stent System (EPS) for the prevention of stroke, today announced that Marvin Slosman, Chief Executive Officer, will deliver a company update presentation at the 23rd Annual Needham Virtual Healthcare Conference, which is being held April 8-11, 2024.
Presentation details:
| Date: | Wednesday, April 10th |
| Time: | 8:00-8:40 AM ET |
| Webcast: | or on the Events section of the company's Investor Relations website at |
About InspireMD, Inc.
InspireMD seeks to utilize its proprietary MicroNet technology to make its products the industry standard for carotid stenting by providing outstanding acute results and durable, stroke-free long-term outcomes. InspireMD's common stock is quoted on the Nasdaq under the ticker symbol NSPR.
We routinely post information that may be important to investors on our website. For more information, please visit .
Investor Contacts:
Craig Shore
Chief Financial Officer
InspireMD, Inc.
888-776-6804
craigs@inspiremd.com
Chuck Padala, Managing Director
LifeSci Advisors
646-627-8390
chuck@lifesciadvisors.com
investor-relations@inspiremd.com
TEL AVIV, Israel and MIAMI, April 03, 2024 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard Embolic Prevention Stent System (EPS) for the prevention of stroke, today announced that Marvin Slosman, Chief Executive Officer, will deliver a company update presentation at the 23rd Annual Needham Virtual Healthcare Conference, which is being held April 8-11, 2024.
以色列特拉維夫和邁阿密，2024年4月3日（環球新聞專線）——用於預防中風的cGuard栓塞預防支架系統（EPS）開發商InspireMD, Inc.（納斯達克股票代碼：NSPR）今天宣佈，首席執行官馬文·斯洛斯曼將在2024年4月8日至11日舉行的第23屆尼德姆年度虛擬醫療大會上發表公司最新情況演講。
Presentation details:
演示詳情：
| Date: | Wednesday, April 10th |
| Time: | 8:00-8:40 AM ET |
| Webcast: | or on the Events section of the company's Investor Relations website at |
| 日期： | 4 月 10 日星期三第四 |
| 時間： | 美國東部時間上午 8:00-8:40 |
| 網絡直播： | 或訪問公司投資者關係網站的 “活動” 部分，網址爲 |
About InspireMD, Inc.
InspireMD seeks to utilize its proprietary MicroNet technology to make its products the industry standard for carotid stenting by providing outstanding acute results and durable, stroke-free long-term outcomes. InspireMD's common stock is quoted on the Nasdaq under the ticker symbol NSPR.
關於 InspireMD, Inc.
InspireMD 希望利用其專有的 MicronET 該技術通過提供卓越的急性療效和持久、無中風的長期療效，使其產品成爲頸動脈支架植入的行業標準。InspireMD的普通股在納斯達克上市，股票代碼爲NSPR。
We routinely post information that may be important to investors on our website. For more information, please visit .
我們經常在我們的網站上發佈可能對投資者很重要的信息。欲了解更多信息，請訪問。
Investor Contacts:
投資者聯繫人：
Craig Shore
Chief Financial Officer
InspireMD, Inc.
888-776-6804
craigs@inspiremd.com
克雷格肖爾
首席財務官
InspireMD, Inc.
888-776-6804
craigs@inspiremd.com
Chuck Padala, Managing Director
LifeSci Advisors
646-627-8390
chuck@lifesciadvisors.com
investor-relations@inspiremd.com
查克·帕達拉，董事總經理
生命科學顧問
646-627-8390
chuck@lifesciadvisors.com
investor-relations@inspiremd.com
譯文內容由第三人軟體翻譯。
風險及免責聲明
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能，分享給你的好友吧